If it is known, for example, that a patient has the reference RBMS3 allele and the alternate WNT5A allele, this might indicate a highly likelihood of developing severe SSc-related lung disease, and testing and treatment of lung disease could be started early and aggressively. This evidence concerns the gene WNT5A and lung disorder.